Dr Mark White
- Clinical Lecturer (Clinical Research Garscube)
The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Hotjar and Clarity help us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
Fetit, R. et al. (2024) Characterising neutrophil subtypes in cancer using scRNA sequencing demonstrates the importance of IL-1β/CXCR2 axis in generation of metastasis specific neutrophils. Cancer Research Communications, 4(2), pp. 588-606. (doi: 10.1158/2767-9764.CRC-23-0319) (PMID:38358352) (PMCID:PMC10903300)
Corry, S. M. et al. (2022) Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer. Gut, 71(12), pp. 2502-2517. (doi: 10.1136/gutjnl-2021-326183) (PMID:35477539) (PMCID:PMC9664095)
Nicoll, R., White, M., Loureiro Harrison, L., Cordiner, R. L.M., Daniel, M., Choo-Kang, B. and Boyle, J. G. (2021) Improving the quality of weekend medical handover on non-receiving medical hospital wards. BMJ Open Quality, 10(4), e000991. (doi: 10.1136/bmjoq-2020-000991)
Welisch, G. et al. (2021) First in Human: who and what makes a cancer phase 1 trial and why are they so important? Project Report. OSF. (doi: 10.17605/OSF.IO/KWHQF).
Watt, D., Roxburgh, C. , White, M., Chan, J., Horgan, P. and McMillan, D. (2015) A survey of attitudes towards the clinical application of systemic inflammation based prognostic scores in cancer. Mediators of Inflammation, 2015, 842070. (doi: 10.1155/2015/842070) (PMID:26504363) (PMCID:PMC4609481)
Fetit, R. et al. (2024) Characterising neutrophil subtypes in cancer using scRNA sequencing demonstrates the importance of IL-1β/CXCR2 axis in generation of metastasis specific neutrophils. Cancer Research Communications, 4(2), pp. 588-606. (doi: 10.1158/2767-9764.CRC-23-0319) (PMID:38358352) (PMCID:PMC10903300)
Corry, S. M. et al. (2022) Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer. Gut, 71(12), pp. 2502-2517. (doi: 10.1136/gutjnl-2021-326183) (PMID:35477539) (PMCID:PMC9664095)
Nicoll, R., White, M., Loureiro Harrison, L., Cordiner, R. L.M., Daniel, M., Choo-Kang, B. and Boyle, J. G. (2021) Improving the quality of weekend medical handover on non-receiving medical hospital wards. BMJ Open Quality, 10(4), e000991. (doi: 10.1136/bmjoq-2020-000991)
Watt, D., Roxburgh, C. , White, M., Chan, J., Horgan, P. and McMillan, D. (2015) A survey of attitudes towards the clinical application of systemic inflammation based prognostic scores in cancer. Mediators of Inflammation, 2015, 842070. (doi: 10.1155/2015/842070) (PMID:26504363) (PMCID:PMC4609481)
Welisch, G. et al. (2021) First in Human: who and what makes a cancer phase 1 trial and why are they so important? Project Report. OSF. (doi: 10.17605/OSF.IO/KWHQF).